Friday, 16 October 2026European Markets

LATECOERE Stock Falls By 35% In The Last 21 Sessions

Loading stream...

french aerostructures and interconnection systems manufacturer, latecoere (cac 40: lat.pa), has been experiencing a significant drop in share price, with an astounding 35% plunge over just 21 sessions - falling from eur0.23 to eur0.13 as of 15:03 est monday. this comes after three consecutive sessions of gains, outpacing france's benchmark cac 40 index which posted a modest 0.02 growth, rising to eur7,313.57.

latecoere's historical performance

since its establishment as a subsidiary of scp skn holding i sas in 1917, latecoere has demonstrated considerable volatility, even with a consistent decline in its share price. the company, which is involved in the manufacture and installation of various aircraft components such as doors, fuselage, and wings, has recorded average weekly, monthly, and quarterly intraday variations of -1.84%, -2.51%, and +3.66% respectively over its ninety day history. while these fluctuations may unnerve certain investors, those with a long-term perspective may see potential for profitable trends amidst short-term volatility.

decline in trading volume

on monday, latecoere's trading volume was significantly lower than its average volume of 179,187. this suggests a decreasing interest from investors and potential signs of underperformance in its trading activity.

financial viability concerns

current financial indicators for latecoere are also concerning. the company's trailing twelve-month earnings per share (eps) stands at negative eur0.18, highlighting its current unprofitability. as an important measure of a company's viability, this negative eps might deter potential investors.

opportunities for recovery

in spite of these concerns, latecoere's stock appears to be oversold according to analysis from the stochastic oscillator - a tool often used for identifying overbought and oversold market conditions. this suggests that the recent sharp decline in share price could lead to a potential upward trend in the near future.

in conclusion, while latecoere currently appears dismal, its volatility and oversold status could indicate brighter prospects, assuming there are no significant shifts in fundamental or macroeconomic factors affecting its performance.

more news about latecoere (lat.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com